StockData
Cingulate Inc. logo

Cingulate Inc. (CING) stock

CINGNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as CINGW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30
$5.11+0.39 (+8.26%)

Close on Nov 18, 2026Market cap $74.31MP/E –Yield –

Cingulate free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Cingulate's free cash flow for the twelve months ending Jun 30, 2026 was -$20.94M. For fiscal 2025 it was -$17.41M. The highest annual figure on record is -$7.21M in fiscal 2020.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$17.41M–
FY2024Dec 31, 2024-$18.66M–
FY2023Dec 31, 2023-$15.26M–
FY2022Dec 31, 2022-$16.04M–
FY2021Dec 31, 2021-$11.25M–
FY2020Dec 31, 2020-$7.21M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$5.97M–
Q1 FY2026Mar 31, 2026-$6.97M–
Q4 FY2025Dec 31, 2025-$3.75M–
Q3 FY2025Sep 30, 2025-$4.24M–
Q4 FY2024Dec 31, 2024-$4.28M–
Q1 FY2024Mar 31, 2024-$8.83M–
Q4 FY2023Dec 31, 2023-$2.75M–
Q3 FY2023Sep 30, 2023-$4.29M–
Q2 FY2023Jun 30, 2023-$4.60M–
Q1 FY2023Mar 31, 2023-$3.61M–
Q4 FY2022Dec 31, 2022-$4.35M–
Q3 FY2022Sep 30, 2022-$3.40M–
Q2 FY2022Jun 30, 2022-$4.41M–
Q1 FY2022Mar 31, 2022-$3.87M–
Q4 FY2021Dec 31, 2021-$5.33M–
Q3 FY2021Sep 30, 2021-$2.60M–
Q2 FY2021Jun 30, 2021-$1.57M–
Q1 FY2021Mar 31, 2021-$1.74M–

More Cingulate figures

See a number that looks wrong?